Limited Impact of Fc-dependent Functions on the Efficacy of the Anti-HIV-1 Broadly Neutralizing Antibody PGT121 in Macaques

被引：0
|
作者：
Parsons, Matthew [1 ]
Lee, Wen Shi [1 ]
Kristensen, Anne [1 ]
Amarasena, Thakshila [1 ]
Khoury, Georges [1 ]
Davenport, Miles [2 ]
Kent, Stephen [1 ]
机构：
[1] Univ Melbourne, Melbourne, Vic, Australia
[2] Kirby Inst, Kensington, NSW, Australia
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P20.03
引用
收藏
页码：339 / 339
页数：1
相关论文
共 44 条
  • [31] Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model
    Veselinovic, Milena
    Neff, C. Preston
    Mulder, Leila R.
    Akkina, Ramesh
    VIROLOGY, 2012, 432 (02) : 505 - 510
  • [32] Contribution of NK Cell Education to both Direct and Anti-HIV-1 Antibody-Dependent NK Cell Functions
    Kristensen, Anne B.
    Kent, Stephen J.
    Parsons, Matthew S.
    JOURNAL OF VIROLOGY, 2018, 92 (11)
  • [33] Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study
    Andrianov, Alexander M.
    Kashyn, Ivan A.
    Tuzikov, Alexander V.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2014, 32 (12): : 1993 - 2004
  • [34] Reactivity-based one-pot synthesis of oligomannoses: Defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody
    Lee, HK
    Scanlan, CN
    Huang, CY
    Chang, AY
    Calarese, DA
    Dwek, RA
    Rudd, PM
    Burton, DR
    Wilson, IA
    Wong, CH
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (08) : 1000 - 1003
  • [35] Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding
    Julien, Jean-Philippe
    Huarte, Nerea
    Maeso, Ruben
    Taneva, Stefka G.
    Cunningham, Annie
    Nieva, Jose L.
    Pai, Emil F.
    JOURNAL OF VIROLOGY, 2010, 84 (09) : 4136 - 4147
  • [36] First-in-human evaluation of safety and pharmacokinetics of intravenous or subcutaneous infusions of PGT121.141.LS, an anti-V3 HIV-1 broadly neutralizing antibody in healthy volunteers without HIV
    Edupuganti, S.
    Hurt, C.
    Stephenson, K.
    Huang, Y.
    Paez, C.
    Gamble, T.
    Yu, C.
    Yen, C.
    Regenold, S.
    Chege, W.
    Landovitz, R. J.
    Mayer, K. H.
    Siegel, M.
    Sobieszczyk, M. E.
    Walsh, S. R.
    Heptinstall, J.
    Seaton, K.
    Montefiori, D.
    Tomaras, G.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 229 - 229
  • [37] The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner
    Tudor, Daniela
    Bomsel, Morgane
    AIDS, 2011, 25 (06) : 751 - 759
  • [38] Potent and Broad Anti-HIV-1 Activity Exhibited by a Glycosyl-Phosphatidylinositol-Anchored Peptide Derived from the CDR H3 of Broadly Neutralizing Antibody PG16
    Liu, Lihong
    Wen, Michael
    Wang, Weiming
    Wang, Shumei
    Yang, Lifei
    Liu, Yong
    Qian, Mengran
    Zhang, Linqi
    Shao, Yiming
    Kimata, Jason T.
    Zhou, Paul
    JOURNAL OF VIROLOGY, 2011, 85 (17) : 8467 - 8476
  • [39] Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone
    Walsh, S.
    Gay, C.
    Sobieszczyk, M.
    Mannheimer, S.
    Hyrien, O.
    Yu, C.
    Seaton, K.
    Skalland, T.
    Dumond, J.
    Andrew, P.
    Karg, C.
    Paez, C.
    Gamble, T.
    He, Z.
    Hanscom, B.
    Dye, B.
    Piwowar-Manning, E.
    Hural, J.
    Polakowski, L.
    Yacovone, M.
    Chege, W.
    Montefiori, D.
    Gama, L.
    Mascola, J.
    Tomaras, G.
    Huang, Y.
    Karuna, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 113 - 114
  • [40] A novel form of carbohydrate recognition. The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1-2 mannose residues on the outer face of GP120
    Rudd, PM
    Scanlan, CN
    Pantophlet, R
    Wormald, MR
    Saphire, EO
    Stanfield, R
    Wilson, IA
    Katinger, H
    Dwek, RA
    Burton, DR
    GLYCOBIOLOGY, 2002, 12 (10) : 648 - 648
12345